The HER2 Inhibitors Global Market Report 2023 by The Business Research Company, provides her2 inhibitors market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.
Learn More On The HER2 Inhibitors Market:
https://www.thebusinessresearchcompany.com/report/her2-inhibitor-global-market-report
According to The Business Research Company’s HER2 Inhibitors Global Market Report 2023, the market size is expected to grow from $7.26 billion in 2022 to $7.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global HER2 inhibitors is expected to grow from $11.5 billion in 2027 at a CAGR of 9.6%.
The rise in the number of breast cancer cases across the globe is likely to contribute to the growth of the HER-2 inhibitors market during the forecast period.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3396&type=smp
The her2 inhibitors market is segmented:
1) By Treatment: Monotherapy, Combination Therapy
2) By Application: Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications
3) By End User: Hospitals, Clinics, Other End Users
Biotechnology companies are focusing on acquiring or partnering with biopharmaceutical companies to develop and promote the HER-2 inhibitor market. In recent years, several collaborations have helped these companies expand their HER-2 inhibitor portfolios, and increase revenues, and share costs. For instance, in June 2020, Alphamab Oncology, a biotechnology company, collaborated with Sanofi, a pharmaceutical company, to investigate KN026 in combination with other drugs for the treatment of HER2 breast cancer. KN026 is a HER2 inhibitor market developed by Alphamab Oncology.
The her2 inhibitors market report table of contents includes:
1. Executive Summary
2. HER2 Inhibitors Market Characteristics
3. HER2 Inhibitors Market Trends And Strategies
4. HER2 Inhibitors Market – Macro Economic Scenario
5. HER2 Inhibitors Market Size And Growth
.
.
.
26. Africa HER2 Inhibitors Market
27. HER2 Inhibitors Market Competitive Landscape And Company Profiles
28. HER2 Inhibitors Pipeline Analysis
29. Key Mergers And Acquisitions In The HER2 Inhibitors Market
30. HER2 Inhibitors Market Future Outlook and Potential Analysis
Top Major Players:
- Hoffmann-La Roche Ltd
- Merck & Co. Inc
- Novartis AG
- Pfizer Inc
- Puma Biotechnology Inc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
